JUNIOR STRENGTH ADVIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Junior Strength Advil, and when can generic versions of Junior Strength Advil launch?
Junior Strength Advil is a drug marketed by Haleon Us Holdings and is included in two NDAs.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Junior Strength Advil
A generic version of JUNIOR STRENGTH ADVIL was approved as ibuprofen by STRIDES PHARMA on September 24th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for JUNIOR STRENGTH ADVIL?
- What are the global sales for JUNIOR STRENGTH ADVIL?
- What is Average Wholesale Price for JUNIOR STRENGTH ADVIL?
Summary for JUNIOR STRENGTH ADVIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 207 |
| Clinical Trials: | 30 |
| Patent Applications: | 4,329 |
| What excipients (inactive ingredients) are in JUNIOR STRENGTH ADVIL? | JUNIOR STRENGTH ADVIL excipients list |
| DailyMed Link: | JUNIOR STRENGTH ADVIL at DailyMed |
Recent Clinical Trials for JUNIOR STRENGTH ADVIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitas Airlangga | N/A |
| 3F Clinical Trials LTDA | Phase 2/Phase 3 |
| FG Brasil LTDA | Phase 2/Phase 3 |
Pharmacology for JUNIOR STRENGTH ADVIL
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for JUNIOR STRENGTH ADVIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | JUNIOR STRENGTH ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944-002 | Dec 18, 1998 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Haleon Us Holdings | JUNIOR STRENGTH ADVIL | ibuprofen | TABLET;ORAL | 020267-002 | Dec 13, 1996 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for JUNIOR STRENGTH ADVIL
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases | Pedea | ibuprofen | EMEA/H/C/000549 Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age. |
Authorised | no | no | no | 2004-07-28 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
